Development code · Small Molecule
NBI-1065844
NBI-1065844 is a development code for Luvadaxistat (TAK-831), developed by Neurocrine Biosciences, Inc..
- Status
- Discontinued for Schizophrenia
- Mechanism
- DAAO Inhibitor
- Developer
- Neurocrine Biosciences, Inc.
Programs
- Luvadaxistat (TAK-831) for SchizophreniaDiscontinuedDiscontinued
Also known as
- TAK-831
- luvadaxistat
- 4-hydroxy-6-[2-[4-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one
- 1425511-32-5